Cannara Biotech Inc.

TSXV LOVE.V

Cannara Biotech Inc. Net Cash Used Provided By Financing Activities for the year ending August 31, 2024: USD -2.33 M

Cannara Biotech Inc. Net Cash Used Provided By Financing Activities is USD -2.33 M for the year ending August 31, 2024, a 15.29% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Cannara Biotech Inc. Net Cash Used Provided By Financing Activities for the year ending August 31, 2023 was USD -2.75 M, a -114.20% change year over year.
  • Cannara Biotech Inc. Net Cash Used Provided By Financing Activities for the year ending August 31, 2022 was USD 19.38 M, a -26.46% change year over year.
  • Cannara Biotech Inc. Net Cash Used Provided By Financing Activities for the year ending August 31, 2021 was USD 26.36 M, a 3,860.26% change year over year.
  • Cannara Biotech Inc. Net Cash Used Provided By Financing Activities for the year ending August 31, 2020 was USD -700.93 K, a -102.20% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
SV Wall Street
TSXV: LOVE.V

Cannara Biotech Inc.

CEO Mr. Zohar Krivorot
IPO Date Jan. 14, 2019
Location Canada
Headquarters 333 Decarie Blvd.
Employees 461
Sector Consumers Staples
Industries
Tobacco Alcoholic Beverages Bread & Bakery Cosmetics Drugstores & Retail Pharmacies Perfumes & Fragrances Personal Care
Description

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

StockViz Staff

February 6, 2025

Any question? Send us an email